Pharma Stocks Rated in Buy
Explore our handpicked list of Pharma Stocks with a 'Buy' rating from external analysts. These pharmaceutical and healthcare companies have been identified as having strong growth prospects and solid fundamentals, offering investors the opportunity to capitalize on the potential of the pharma market. (Analyst Data curated by S&P Global)
More Collections >
| Name | Analyst Rating | Price | Target Price | M Cap | Alpha | 1Y Return | 3Y Return | 5Y Return | PE | Industry PE | PB | Beta | Div Yld | Net Profit Qtr | Net Profit QoQ % | Net Profit YoY % | Net Profit 3Y Change % | Rev Qtr (in Cr) | Rev QoQ (in %) | Rev 1Y change % | Rev 3Y change % | Profit Mar Qtr | Profit Mar QoQ | Profit Mar 1Y Change% | Profit Mar 3Y Change% | Sector | M Cap | ROE | ROCE | EPS | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries Ltd | BUY | ₹1,745.20 | 2047.89 | Large Cap | 7.29% | 18.24% | 99.59% | 280.99% | 37.05 | 53.69 | 16.41 | 0.62 | 0.83% | 2917.54 Cr | 12.7% | 322.31% | 13436.94 | 1.3% | 10.51% | 44.77% | 19.89% | 1.99% | 191.7% | Basic Materials | 424010.48 | 12.05% | 12.22% | 40.21 | 960335 | ||
 Cipla Ltd | BUY | ₹1,479.80 | 1640.92 | Large Cap | 9.42% | 58.46% | 153.7% | 24.06 | 53.69 | 4.31 | 0.54 | 0.87% | 1583.72 Cr | 21.26% | 46.55% | 73.04% | 6961.6 | 0.01% | 13.28% | 34.52% | 16.12% | 21.26% | 29.37% | 28.64% | Basic Materials | 120079.97 | 15.5% | 20.1% | 51.47 | 929794 | |
 Torrent Pharmaceuticals Ltd | BUY | ₹3,135.00 | 3612.18 | Large Cap | 14.28% | 26.2% | 145.33% | 155.28% | 57.89 | 53.69 | 12.89 | 0.5 | 1.08% | 503 Cr | 11.04% | 33.02% | 32.31% | 2762 | 11.51% | 34.02% | 15.44% | 13.81% | 19.28% | Basic Materials | 107817.11 | 20.43% | 20.4% | 48.94 | 520841 | ||
 Mankind Pharma Ltd | BUY | ₹2,403.00 | 2789.59 | Large Cap | 2.93% | 12.35% | 71.52% | 71.52% | 47.92 | 53.69 | 9.56 | 0.51 | NA | 384.52 Cr | 48.26% | 50.17% | 3230 | 4.99% | 18.12% | 66.3% | 18.79% | 25.52% | Pharmaceuticals | 100648.53 | 20.95% | 25.77% | 48.47 | 520671 | |||
 Lupin Ltd | BUY | ₹2,039.70 | 2272.5 | Large Cap | 15.83% | 27.2% | 174.85% | 137.23% | 32.02 | 53.69 | 3.58 | 0.7 | 0.49% | 858.86 Cr | 332.35% | 57.63% | 5618.56 | 2.21% | 20.25% | 31.97% | 9.67% | 259.55% | 19.44% | Basic Materials | 91999.1 | 11.92% | 13.96% | 42.47 | 508252 | ||
 Aurobindo Pharma Ltd | BUY | ₹1,164.20 | 1470.82 | Mid Cap | 3.79% | 88.44% | 74.21% | 19.37 | 53.69 | 3.24 | 0.83 | 0.41% | 845.57 Cr | 3.5% | 64.4% | 7893.15 | 3.23% | 16.68% | 17.06% | 10.93% | 0.27% | 40.89% | Basic Materials | 67828.25 | 10.35% | 11.74% | 54.09 | 604990 | |||
 Abbott India Ltd | BUY | ₹30,100.00 | 30645.25 | Mid Cap | 6.85% | 17.38% | 79.65% | 67.55% | 0 | 53.69 | 15.48 | 0.46 | NA | 360.78 Cr | 0.61% | 16.35% | 0% | 1614.28 | 14.52% | 0% | 14.18% | 1.75% | 1.6% | 0% | Basic Materials | 63760.63 | 34.88% | 44.71% | 35.67 | 3249 | |
 Glaxosmithkline Pharmaceuticals Ltd | BUY | ₹2,760.20 | 2617.75 | Mid Cap | 27.38% | 38.84% | 79.53% | 93.03% | 54.46 | 53.69 | 18.45 | 0.78 | 1.65% | 229.88 Cr | 64.72% | 949.42 | 6.21% | 18.05% | 17.08% | 39.54% | Basic Materials | 46473.16 | 36.83% | 44.44% | 34.83 | 59745 | |||||
 Biocon Ltd | BUY | ₹330.30 | 380.95 | Mid Cap | 0.15% | 12.04% | 39.5 | 53.69 | 2.91 | 1.28 | 0.19% | 459.4 Cr | 466.46% | 101.84% | 53.37% | 4358.1 | 15.51% | 32.05% | 106.57% | 8.8% | 390.41% | 52.85% | Basic Materials | 40172.08 | 0.97% | 2.61% | 10.81 | 5865512 | |||
 Glenmark Pharmaceuticals Ltd | BUY | ₹1,397.60 | 1690.92 | Mid Cap | 30.06% | 41.94% | 241.33% | 323.3% | -227.75 | 53.69 | 1.18 | 0.97 | 0.26% | 348.03 Cr | 3301.9 | 1.98% | 7.94% | 1.11% | Basic Materials | 40041.47 | 6.98% | 9.75% | 422610 | ||||||||
 Ipca Laboratories Ltd | BUY | ₹1,363.00 | 1608.57 | Mid Cap | 5.08% | 36.73% | 73.6% | 46.92 | 53.69 | 4.95 | 0.72 | 0.32% | 277.33 Cr | 12.99% | 7.58% | 2245.37 | 23.39% | 42.16% | 6.87% | 18.5% | Basic Materials | 34237.38 | 9.81% | 14.12% | 20.86 | 144784 | |||||
 Ajanta Pharma Ltd | BUY | ₹2,526.20 | 3076.17 | Mid Cap | 4.54% | 119.43% | 155.24% | 34.32 | 53.69 | 8.28 | 0.68 | 2.29% | 225.26 Cr | 38.81% | 24.82% | 1170.41 | 2.12% | 12.45% | 45.65% | 19.39% | 23.44% | Basic Materials | 31466.61 | 24.24% | 32.49% | 64.6 | 43638 |